TUMORAMP Trademark

Trademark Overview


On Wednesday, June 19, 2019, a trademark application was filed for TUMORAMP with the United States Patent and Trademark Office. The USPTO has given the TUMORAMP trademark a serial number of 88480782. The federal status of this trademark filing is REGISTERED as of Tuesday, April 7, 2020. This trademark is owned by Jinfiniti Precision Medicine, Inc.. The TUMORAMP trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

ex vivo cell culturing for tumor cell expansion from a variety of tumor specimen types including resected tumor tissue, tissue biopsy, PAP test samples, bone marrow biopsies, ascites, pleural effusion (PE) and blood to provide cells for medical testing in the nature of cancer drug sensitivity tests and genetic and genomic tests, all for diagnostic or treatment purposes

medical laboratory services, namely, ex vivo cell culturing for tumor cell expansion from a variety of tumor specimen types including resected tumor tissue, tissue biopsy, PAP test samples, bone marrow biopsies, ascites, pleural effusion (PE) and blood to provide cells for medical testing in the nature of anticancer drug development
tumoramp

General Information


Serial Number88480782
Word MarkTUMORAMP
Filing DateWednesday, June 19, 2019
Status700 - REGISTERED
Status DateTuesday, April 7, 2020
Registration Number6027035
Registration DateTuesday, April 7, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 21, 2020

Trademark Statements


Pseudo MarkTUMOR AMP
Goods and Servicesex vivo cell culturing for tumor cell expansion from a variety of tumor specimen types including resected tumor tissue, tissue biopsy, PAP test samples, bone marrow biopsies, ascites, pleural effusion (PE) and blood to provide cells for medical testing in the nature of cancer drug sensitivity tests and genetic and genomic tests, all for diagnostic or treatment purposes
Goods and Servicesmedical laboratory services, namely, ex vivo cell culturing for tumor cell expansion from a variety of tumor specimen types including resected tumor tissue, tissue biopsy, PAP test samples, bone marrow biopsies, ascites, pleural effusion (PE) and blood to provide cells for medical testing in the nature of anticancer drug development

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 11, 2019
Primary Code042
First Use Anywhere DateTuesday, January 1, 2019
First Use In Commerce DateMonday, April 1, 2019

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, June 30, 2019
Primary Code044
First Use Anywhere DateTuesday, January 1, 2019
First Use In Commerce DateMonday, April 1, 2019

Trademark Owner History


Party NameJinfiniti Precision Medicine, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAugusta, GA 30912

Party NameJinfiniti Precision Medicine, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAugusta, GA 30912

Party NameJinfiniti Precision Medicine, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAugusta, GA 30912

Trademark Events


Event DateEvent Description
Saturday, June 22, 2019NEW APPLICATION ENTERED
Sunday, June 30, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 18, 2019NON-FINAL ACTION WRITTEN
Tuesday, September 10, 2019ASSIGNED TO EXAMINER
Wednesday, September 18, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 18, 2019NON-FINAL ACTION E-MAILED
Tuesday, December 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 10, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 11, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 12, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 12, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 13, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 17, 2019ASSIGNED TO LIE
Wednesday, January 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 21, 2020PUBLISHED FOR OPPOSITION
Tuesday, January 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 7, 2020REGISTERED-PRINCIPAL REGISTER
Monday, April 7, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 10, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED